InsidersTradesSigma
Meds Apotek AB: insider trades · Finland · FIN-FSA
FI:meds-apotek-abSE0018014110FI·FIN-FSAMcap 407M€Consumer Cyclical
Discover the full insider trade history of Meds Apotek AB, a listed issuer based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Consumer Cyclical sector, Meds Apotek AB has recorded 9 reports. Market capitalisation: €406.7m. The latest transaction was disclosed on 8 May 2026 — Purchase. Among the most active insiders: Björn Thorngren. Every trade is openly available.
9
Insider Decl.
0
Thresholds
€113,604
5 ops.
Buy Volume
€1m
3 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
21.90 €
Analyst consensus
2 analystsStrong buy
40.00 €Target 47.50 €(+117%)55.00 €
Income statement
Revenue1.01 Bn€
Gross profit278.2 M€28% margin
Net income7.7 M€0.7% margin
Valuation
PER (trailing)56.2x
PER (forward)9.0x
P/Book3.2x
Balance sheet & cash
Market cap406.7 M€
Total debt7.0 M€
Free Cash Flow−28.8 M€
Debt / Equity4%
Profitability & ownership
ROE7.9%
% insiders40.7%
% institutions15.3%
Last declaration on 8 May 2026
Declarations9 total
Executives●Purchase19FIN-FSA
€9,0924,000 shares@ €2.27290.0022% mcap100.0% of flow
Aktie
FI:A003Y329-1·
Ideal exit: 2 Feb 2027 (T+270)
Executives●Purchase26FIN-FSA
€16761 shares@ €2.73250.0000% mcap0.0% of flow
Aktie
FI:A003Y207-1·
Ideal exit: 30 Jan 2027 (T+270)
Executives●Purchase26FIN-FSA
€782236 shares@ €3.31380.0002% mcap0.1% of flow
Aktie
FI:A003W632-1·
Ideal exit: 27 Nov 2026 (T+270)
Executives●Other37FIN-FSA
€3m622,641 shares@ €4.84880.74% mcap100.0% of flow
Aktie
FI:A003T179-1·
Executives●Purchase19FIN-FSA
€2,687560 shares@ €4.79750.0007% mcap100.0% of flow
Aktie
FI:A003S589-1·
Ideal exit: 19 Jun 2026 (T+270)
Executives●Sale19FIN-FSA
€17,9913,750 shares@ €4.79750.0044% mcap100.0% of flow
Aktie
FI:A003S580-1·
Executives●Sale42FIN-FSA
€873,348182,042 shares@ €4.79750.21% mcap99.9% of flow
Aktie
FI:A003S576-1·
Executives●Sale25FIN-FSA
€276,23657,579 shares@ €4.79750.068% mcap100.0% of flow
Aktie
FI:A003S575-2·
Executives●Purchase22FIN-FSA
€100,87721,000 shares@ €4.80370.025% mcap100.0% of flow
Aktie
FI:A003S552-1·
Ideal exit: 20 Jun 2026 (T+270)
9 of 9 declarations